Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies.

Yutani S, Shirahama T, Muroya D, Matsueda S, Yamaguchi R, Morita M, Shichijo S, Yamada A, Sasada T, Itoh K.

Cancer Sci. 2017 Sep;108(9):1732-1738. doi: 10.1111/cas.13301. Epub 2017 Jul 23.

2.

Evaluation of Surgical Procedures for T2 Gallbladder Cancer in Terms of Recurrence and Prognosis.

Kawahara R, Shirahama T, Arai S, Muroya D, Nomura Y, Fukutomi S, Shirahama N, Takagi K, Goto Y, Akashi M, Maruyama Y, Sakai H, Ishikawa H, Hisaka T, Yasunaga M, Horiuchi H, Okuda K, Akagi Y, Tanaka H.

Kurume Med J. 2017 Apr 13;63(1.2):15-22. doi: 10.2739/kurumemedj.MS65005. Epub 2017 Mar 22.

3.

A randomized phase II trial of personalized peptide vaccine with low dose cyclophosphamide in biliary tract cancer.

Shirahama T, Muroya D, Matsueda S, Yamada A, Shichijo S, Naito M, Yamashita T, Sakamoto S, Okuda K, Itoh K, Sasada T, Yutani S.

Cancer Sci. 2017 May;108(5):838-845. doi: 10.1111/cas.13193. Epub 2017 May 5.

4.

[A Case of Multiple Venous Thromboses Associated with Acute Cytomegalovirus Infection].

Nishimura N, Ueda N, Kawaguchi T, Shirahama T, Himeji D, Yamanaka A.

Kansenshogaku Zasshi. 2017 Jan;91(1):20-4. Japanese.

PMID:
30277683
5.

A case of retrograde intussusception at Roux-en-Y anastomosis 10 years after total gastrectomy: review of the literature.

Kitasato Y, Midorikawa R, Uchino Y, Saku S, Minami T, Shirahama T, Kiyomatsu K, Okuda K, Akagi Y, Tanaka H.

Surg Case Rep. 2016 Dec;2(1):123. Epub 2016 Nov 3.

6.

[Streptococcal Toxic Shock-like Syndrome due to Streptococcus suis Serotype 2 in a Japanese Pig Farmer].

Yamanaka A, Shirahama T, Nishimura N, Ueda N, Himeji D, Kawaguchi T, Ueda A.

Kansenshogaku Zasshi. 2015 Nov;89(6):741-4. Japanese.

PMID:
26821523
7.

Exposure to negatively charged-particle dominant air-conditions on human lymphocytes in vitro activates immunological responses.

Nishimura Y, Takahashi K, Mase A, Kotani M, Ami K, Maeda M, Shirahama T, Lee S, Matsuzaki H, Kumagai-Takei N, Yoshitome K, Otsuki T.

Immunobiology. 2015 Dec;220(12):1359-68. doi: 10.1016/j.imbio.2015.07.006. Epub 2015 Jul 17.

PMID:
26213096
8.

Enhancement of NK Cell Cytotoxicity Induced by Long-Term Living in Negatively Charged-Particle Dominant Indoor Air-Conditions.

Nishimura Y, Takahashi K, Mase A, Kotani M, Ami K, Maeda M, Shirahama T, Lee S, Matsuzaki H, Kumagai-Takei N, Yoshitome K, Otsuki T.

PLoS One. 2015 Jul 14;10(7):e0132373. doi: 10.1371/journal.pone.0132373. eCollection 2015.

9.

[A case of postoperative recurrent hilar cholangiocarcinoma in the lower bile duct treated with pancreatoduodenectomy].

Kawahara R, Tanigawa M, Horiuchi H, Takahashi K, Shirahama T, Nakama Y, Takagi H, Hirakawa Y, Maruyama Y, Sakai H, Ishikawa H, Hisaka T, Yasunaga M, Okuda K.

Gan To Kagaku Ryoho. 2014 Nov;41(12):1518-20. Review. Japanese.

PMID:
25731238
10.

Blackout during meals: A case report of swallow syncope due to sinus arrest.

Okahara A, Nagamoto Y, Umemoto S, Matsuura T, Ozaki K, Nakano Y, Takegami K, Mine D, Shirahama T, Koga Y, Yoshida K, Sadamatsu K, Hayashida K.

J Cardiol Cases. 2014 Jun 28;10(3):91-93. doi: 10.1016/j.jccase.2014.05.006. eCollection 2014 Sep.

11.

Resolution of a left ventricular thrombus by the thrombolytic action of dabigatran.

Nagamoto Y, Shiomi T, Matsuura T, Okahara A, Takegami K, Mine D, Shirahama T, Koga Y, Yoshida K, Sadamatsu K, Hayashida K.

Heart Vessels. 2014 Jul;29(4):560-2. doi: 10.1007/s00380-013-0403-5. Epub 2013 Sep 5.

PMID:
24005764
12.

Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients' Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine.

Yutani S, Komatsu N, Matsueda S, Yoshitomi M, Shirahama T, Yamada A, Itoh K, Sasada T.

Evid Based Complement Alternat Med. 2013;2013:981717. doi: 10.1155/2013/981717. Epub 2013 Jun 10.

13.

Ventricular pacing inhibition by oversensing due to diaphragmatic myopotential during deep inspiration.

Nagamoto Y, Shiomi T, Matsuura T, Okahara A, Inoue K, Yamaguchi R, Takegami K, Mine D, Shirahama T, Koga Y, Yoshida K, Sadamatsu K, Hayashida K.

J Cardiol Cases. 2013 Jun 25;8(2):e81-e84. doi: 10.1016/j.jccase.2013.04.008. eCollection 2013 Aug.

14.

Current status of immunotherapy for the treatment of biliary tract cancer.

Takahashi R, Yoshitomi M, Yutani S, Shirahama T, Noguchi M, Yamada A, Itoh K, Sasada T.

Hum Vaccin Immunother. 2013 May;9(5):1069-72. doi: 10.4161/hv.23844. Epub 2013 Feb 1. Review.

15.

Two weeks of permanence in negatively-charged air conditions causes alteration of natural killer cell function.

Takahashi K, Otsuki T, Mase A, Kawado T, Kotani M, Nishimura Y, Maeda M, Murakami S, Kumagai N, Hayashi H, Chen Y, Shirahama T, Miura Y, Morimoto K.

Int J Immunopathol Pharmacol. 2009 Apr-Jun;22(2):333-42.

PMID:
19505387
16.

Inhibitory effect of (-)-epigallocatechin and (-)-epigallocatechin gallate against heregulin beta1-induced migration/invasion of the MCF-7 breast carcinoma cell line.

Kushima Y, Iida K, Nagaoka Y, Kawaratani Y, Shirahama T, Sakaguchi M, Baba K, Hara Y, Uesato S.

Biol Pharm Bull. 2009 May;32(5):899-904.

17.

[Accuracy of COPD questionnaires in the general health check-up setting].

Arimura Y, Yamazaki S, Shirahama T, Matsukura S, Chiyotanda S, Nakazato M, Fukuhara S.

Nihon Kokyuki Gakkai Zasshi. 2008 Sep;46(9):693-9. Japanese.

PMID:
18939410
18.

Attempt to detect natural anticancer compounds--protein binding through precursor ion scan and MS/MS measurements.

Negishi J, Shirahama T, Nagaoka Y, Takemoto Y, Uesato S.

Yakugaku Zasshi. 2008 Sep;128(9):1317-23.

19.

[A case of lung cancer with hyperthyroidism].

Shirahama T, Ashitani J, Kodama T, Kyoraku Y, Sano A, Matsumoto N, Yonekawa T, Nakazato M.

Nihon Kokyuki Gakkai Zasshi. 2008 Apr;46(4):308-13. Japanese.

PMID:
18516995
20.

Negatively-charged air conditions and responses of the human psycho-neuro-endocrino-immune network.

Takahashi K, Otsuki T, Mase A, Kawado T, Kotani M, Ami K, Matsushima H, Nishimura Y, Miura Y, Murakami S, Maeda M, Hayashi H, Kumagai N, Shirahama T, Yoshimatsu M, Morimoto K.

Environ Int. 2008 Aug;34(6):765-72. doi: 10.1016/j.envint.2008.01.003. Epub 2008 Mar 4.

PMID:
18295333
21.

Inhibition of 5-lipoxygenase pathway suppresses the growth of bladder cancer cells.

Hayashi T, Nishiyama K, Shirahama T.

Int J Urol. 2006 Aug;13(8):1086-91.

22.

Stereoselective conversion of anhydrovinblastine into vinblastine utilizing an anti-vinblastine monoclonal antibody as a chiral mould.

Shirahama T, Kohno T, Kaijima T, Nagaoka Y, Morimoto D, Hirata K, Uesato S.

Chem Pharm Bull (Tokyo). 2006 May;54(5):665-8.

23.
24.

Overexpression of cyclooxygenase-2 in high-grade human transitional cell carcinoma of the upper urinary tract.

Oku S, Higashi M, Imazono Y, Sueyoshi K, Enokida H, Kubo H, Yonezawa S, Shirahama T.

BJU Int. 2003 Jan;91(1):109-14.

25.

A case of agranulocytosis associated with severe acute hepatitis B.

Iwamoto J, Hakozaki Y, Sakuta H, Kobari S, Kayashima S, Fujioka T, Ooba K, Shirahama T.

Hepatol Res. 2001 Oct;21(2):181-185.

PMID:
11551838
26.
27.

Overexpression of cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder.

Shirahama T, Sakakura C.

Clin Cancer Res. 2001 Mar;7(3):558-61.

29.

Expression of thymidine phosphorylase as an indicator of poor prognosis for patients with transitional cell carcinoma of the bladder.

Arima J, Imazono Y, Takebayashi Y, Nishiyama K, Shirahama T, Akiba S, Furukawa T, Akiyama S, Ohi Y.

Cancer. 2000 Mar 1;88(5):1131-8.

PMID:
10699904
30.

Infrequent activation of mitogen-activated protein kinase in human colon cancers.

Sakakura C, Hagiwara A, Shirahama T, Nakanishi M, Yasuoka R, Fujita Y, Inazawa J, Abe T, Kohno M, Yamagishi H.

Hepatogastroenterology. 1999 Sep-Oct;46(29):2831-4.

PMID:
10576355
31.

Endorectal ultrasonography for the assessment of rectal wall invasion in intrapelvic tumor: a preliminary report.

Shirahama T, Niwa K, Katsura Y, Yamada K, Nagayama K, Yanase I, Aikou T, Ohi Y.

Int J Urol. 1999 Jun;6(6):293-7.

32.

Expression of Thrombomodulin in the epithelium of the urinary bladder: a possible source of urinary thrombomodulin.

Obama H, Obama K, Takemoto M, Soejima Y, Shirahama T, Ohi Y, Yoshida H, Qzawa M, Muramatsu T, Maruyama I.

Anticancer Res. 1999 Mar-Apr;19(2A):1143-7.

PMID:
10368666
33.

Multidisciplinary treatment, including laser hyperthermia, for extensive regional metastasis of a penile tumor.

Shirahama T, Enokida H, Yanase I, Nobori T, Ohyama M, Ohi Y.

Int J Urol. 1999 Jan;6(1):53-5.

34.

Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease.

Fukuda S, Shirahama T, Imazono Y, Tsushima T, Ohmori H, Kayajima T, Take S, Nishiyama K, Yonezawa S, Akiba S, Akiyama S, Ohi Y.

Cancer. 1999 Mar 15;85(6):1323-30.

PMID:
10189138
35.

[Outbreak of diarrhea due to SRSV infection].

Kayashima N, Abe S, Akanuma M, Arai K, Takei K, Mitani K, Oniwa K, Aoki H, Yasuda H, Shirahama T, Natori K.

Nihon Naika Gakkai Zasshi. 1998 Dec 10;87(12):2504-6. Japanese. No abstract available.

PMID:
9922671
36.

A new treatment for penile conservation in penile carcinoma: a preliminary study of combined laser hyperthermia, radiation and chemotherapy.

Shirahama T, Takemoto M, Nishiyama K, Nobori T, Kawahara M, Ohyama M, Ohi Y.

Br J Urol. 1998 Nov;82(5):687-93.

PMID:
9839584
37.

Selectivity of sphingosine-induced apoptosis. Lack of activity of DL-erythyro-dihydrosphingosine.

Sakakura C, Sweeney EA, Shirahama T, Hagiwara A, Yamaguchi T, Takahashi T, Hakomori S, Igarashi Y.

Biochem Biophys Res Commun. 1998 May 29;246(3):827-30.

PMID:
9618297
38.

Inhibition of MAP kinase by sphingosine and its methylated derivative, N,N-dimethylsphingosine.

Sakakura C, Sweeney E, Shirahama T, Ruan F, Solca F, Kohno M, Hakomori S, Fischer E, Igarashi Y.

Int J Oncol. 1997 Jul;11(1):31-9.

PMID:
21528177
39.

Sphingosine induces apoptosis in androgen-independent human prostatic carcinoma DU-145 cells by suppression of bcl-X(L) gene expression.

Shirahama T, Sakakura C, Sweeney EA, Ozawa M, Takemoto M, Nishiyama K, Ohi Y, Igarashi Y.

FEBS Lett. 1997 Apr 21;407(1):97-100.

40.

Metanestin, a glycoprotein with metastasis-associated expression in transitional cell carcinoma of the urinary bladder.

Takemoto M, Shirahama T, Miyauchi T, Matsusako T, Kaneda N, Muramatsu H, Ozawa M, Ohi Y, Muramatsu T.

Int J Cancer. 1997 Feb 20;74(1):7-14.

41.

In vitro and in vivo induction of apoptosis by sphingosine and N, N-dimethylsphingosine in human epidermoid carcinoma KB-3-1 and its multidrug-resistant cells.

Shirahama T, Sweeney EA, Sakakura C, Singhal AK, Nishiyama K, Akiyama S, Hakomori S, Igarashi Y.

Clin Cancer Res. 1997 Feb;3(2):257-64.

42.

Overexpression of bax sensitizes breast cancer MCF-7 cells to cisplatin and etoposide.

Sakakura C, Sweeney EA, Shirahama T, Igarashi Y, Hakomori S, Tsujimoto H, Imanishi T, Ogaki M, Ohyama T, Yamazaki J, Hagiwara A, Yamaguchi T, Sawai K, Takahashi T.

Surg Today. 1997;27(7):676-9.

PMID:
9306577
43.

Overexpression of bax enhances the radiation sensitivity in human breast cancer cells.

Sakakura C, Sweeney EA, Shirahama T, Igarashi Y, Hakomori S, Tsujimoto H, Imanishi T, Ohgaki M, Yamazaki J, Hagiwara A, Sawai K, Yamaguchi T, Takahashi T.

Surg Today. 1997;27(1):90-3.

PMID:
9035310
44.

Long-term prognosis of chronic hepatitis C after treatment with interferon alpha 2b and characterization of incomplete responders.

Hakozaki Y, Shirahama T, Katou M, Nakagawa K, Oba K, Yoshii O, Matsumoto T, Kuwabara N, Mitamura K.

Am J Gastroenterol. 1996 Oct;91(10):2144-9.

PMID:
8855738
45.

Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis.

Sakakura C, Sweeney EA, Shirahama T, Igarashi Y, Hakomori S, Nakatani H, Tsujimoto H, Imanishi T, Ohgaki M, Ohyama T, Yamazaki J, Hagiwara A, Yamaguchi T, Sawai K, Takahashi T.

Int J Cancer. 1996 Jul 3;67(1):101-5.

46.

Sphingosine and its methylated derivative N,N-dimethylsphingosine (DMS) induce apoptosis in a variety of human cancer cell lines.

Sweeney EA, Sakakura C, Shirahama T, Masamune A, Ohta H, Hakomori S, Igarashi Y.

Int J Cancer. 1996 May 3;66(3):358-66.

47.
48.

[Long term/intermittent treatment of chronic hepatitis C with recombinant interferon alfa-2b].

Hakozaki Y, Fujioka T, Katou M, Kondo T, Oba K, Nakagawa K, Shirahama T.

Nihon Rinsho. 1995 Sep;53 Suppl(Pt 1):1001-6. Japanese. No abstract available.

PMID:
7563656
49.

A controlled study to determine the optimal dose regimen of interferon-alpha 2b in chronic hepatitis C.

Hakozaki Y, Shirahama T, Katou M, Nakagawa K, Oba K, Mitamura K.

Am J Gastroenterol. 1995 Aug;90(8):1246-9.

PMID:
7639224
50.

Intravesical instillation chemotherapy of adriamycin with or without verapamil for the treatment of superficial bladder cancer: the final results of a collaborative randomized trial.

Tsushima T, Ohmori H, Ohi Y, Shirahama T, Kawahara M, Matsumura Y, Ohashi Y.

Cancer Chemother Pharmacol. 1994;35 Suppl:S69-75.

PMID:
7994791

Supplemental Content

Loading ...
Support Center